Marco Filetti
Cited by
Cited by
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
A Cortellini, M Bersanelli, S Buti, K Cannita, D Santini, F Perrone, R Giusti, ...
Journal for immunotherapy of cancer 7 (1), 57, 2019
The psychophysiology primer: a guide to methods and a broad review with a focus on human-computer interaction
BU Cowley, M Filetti, K Lukander, J Torniainen, A Helenius, L Ahonen, ...
Foundations and Trends in Human-Computer Interaction, 2016
Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study
A Cortellini, S Buti, D Santini, F Perrone, R Giusti, M Tiseo, M Bersanelli, ...
The oncologist 24 (6), e327, 2019
Subliminal Salience Search Illustrated: EEG Identity and Deception Detection on the Fringe of Awareness
H Bowman, M Filetti, D Janssen, L Su, A Alsufyani, B Wyble
PLOS One 8 (1), e54258, 2013
Correlations between the immune-related adverse events spectrum and efficacy of anti-PD1 immunotherapy in NSCLC patients
A Cortellini, R Chiari, B Ricciuti, G Metro, F Perrone, M Tiseo, M Bersanelli, ...
Clinical lung cancer 20 (4), 237-247. e1, 2019
Countering countermeasures: Detecting identity lies by detecting conscious breakthrough
H Bowman, M Filetti, A Alsufyani, D Janssen, L Su
PloS one 9 (3), e90595, 2014
The cost of space independence in P300-BCI spellers
S Chennu, A Alsufyani, M Filetti, AM Owen, H Bowman
Journal of neuroengineering and rehabilitation 10 (1), 82, 2013
Attention is more than prediction precision [Commentary on target article]
H Bowman, M Filetti, B Wyble, C Olivers
Behavioral and Brain Sciences 36 (3), 206-208, 2013
Predictive biomarkers for checkpoint inhibitor-based immunotherapy: the galectin-3 signature in NSCLCs
C Capalbo, G Scafetta, M Filetti, P Marchetti, A Bartolazzi
International journal of molecular sciences 20 (7), 1607, 2019
Effective treatment of a platinum‑resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition
C Capalbo, F Belardinilli, M Filetti, C Parisi, M Petroni, V Colicchia, ...
Molecular and clinical oncology 9 (1), 30-34, 2018
Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma: case report and literature review
R Falcone, M Roberto, M Filetti, E Anselmi, P Marchetti
Medicine 97 (3), 2018
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death …
A Cortellini, M Bersanelli, D Santini, S Buti, M Tiseo, K Cannita, F Perrone, ...
European Journal of Cancer 128, 17-26, 2020
Resolution of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) during Nivolumab therapy for non-small cell lung cancer: a case report.
M Filetti, E Anselmi, S Macrini, F Rizzo, D Iacono, R Giusti, P Marchetti
Seminars in arthritis and rheumatism 48 (2), e17, 2018
A new method for detecting deception in Event Related Potentials using individual-specific weight templates
A Alsufyani, A Zoumpoulaki, M Filetti, H Bowman
BMC neuroscience 14 (S1), P34, 2013
Breakthrough percepts of famous faces
A Alsufyani, O Hajilou, A Zoumpoulaki, M Filetti, H Alsufyani, CJ Solomon, ...
Psychophysiology 56 (1), e13279, 2019
Latency as a region contrast: Measuring ERP latency differences with dynamic time warping
A Zoumpoulaki, A Alsufyani, M Filetti, M Brammer, H Bowman
Psychophysiology 52 (12), 1559-1576, 2015
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of≥ 50.
A Cortellini, M Tiseo, GL Banna, F Cappuzzo, JGJV Aerts, F Barbieri, ...
Cancer immunology, immunotherapy: CII, 2020
The use of fentanyl in pain management in head and neck cancer patients: a narrative review
R Giusti, P Bossi, M Mazzotta, M Filetti, D Iacono, P Marchetti
British journal of pain 12 (3), 155-162, 2018
Human computer interaction meets psychophysiology: a critical perspective
MM Spapé, M Filetti, MJA Eugster, G Jacucci, N Ravaja
International Workshop on Symbiotic Interaction, 145-158, 2015
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes
A Cortellini, A Leonetti, A Catino, P Pizzutillo, B Ricciuti, A De Giglio, ...
Clinical and Translational Oncology, 1-8, 2019
The system can't perform the operation now. Try again later.
Articles 1–20